Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04876313
Status:
RECRUITING
Last Update Posted:
2022-04-06
First Post:
2021-04-28
Brief Title:
An Open Label Single-arm Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer NURE-Combo
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Organization Data
Organization:
IRCCS San Raffaele
Class:
OTHER
Study ID:
NURE-Combo
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
IRCCS San Raffaele
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Andrea Necchi
Responsible Party Title:
Associate Professor - Head of Genitourinary Medical Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
IRCCS San Raffaele
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |